Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 15, 2026
- Accession no.
- 0001231589-26-000002
- Filed
- Jan 15, 2026
- Trade date
- Jan 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.90M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | MOption exerciseAcquired | +8,300 | $146.03 | +$1,212,049 | 45,081 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −1,439 | $468.32F2 | −$673,912.48 | 43,642 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −1,307 | $470.37F3 | −$614,773.59 | 42,335 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −407 | $472.28F4 | −$192,217.96 | 41,928 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −3,531 | $469.34F5 | −$1,657,239.54 | 38,397 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −1,576 | $471.44F6 | −$742,989.44 | 36,821 | Direct | |
| Jan 15, 2026 | Common Stock | SSaleDisposed | −40 | $474.74 | −$18,989.6 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Common Stock | MOption exerciseDisposed | −8,300 | $0.00 | $0 | 58,400 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $467.815 to $468.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $469.92 to $470.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $472.13 to $472.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $468.84 to $469.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $471.00 to $471.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.